PBH Prestige Consumer Healthcare Earnings and EPS analysis

  1. Stocks
  2. Healthcare
  3. NYSE: PBH
  4. Earnings
Sign up for free to view scoring metrics ?
Relative Growth: Rel. Growth:
Relative Strength: Rel. Strength:
Relative Valuation: Rel. Valuation:
Relative Profitability: Rel. Profitability: 65

EPS in 2026 (TTM): $3.58

Last Report Period Date: Jun 30, 2026

Based on the company's latest reports for June 2026, the current 12-month EPS is $3.58. Prestige Consumer Healthcare's earnings per share in 2026 was reported at $3.93, marking a decline from $4.32 in 2025. In the quarterly report ending on Jun 30, 2026, PBH's earnings per share amounted to $0.61.

PBH earnings history

Historical annual and quarterly earnings per share (EPS) data for Prestige Consumer Healthcare
EPS (TTM)
$3.58
EPS Growth YoY (Quarterly)
-36.5%
EPS (Quarterly)
$0.61
EPS Growth (Quarterly)
-46%

Prestige Consumer Healthcare had an yealy earnings per share of $3.93, showing a decline of 9% from $4.32 recorded in 2025. The quarterly earnings per share for the period ending Jun 30, 2026, was $0.61, showing a 36.5% decline compared to the same quarter last year. The trailing twelve months EPS for PBH is $3.58 as of June 2026. Prestige Consumer Healthcare's full-year EPS for 2025 was $4.32, a 2.6% rise compared to the previous year.

PBH EPS vs price chart

PBH EPS growth history

Earnings per share growth rates over time
EPS Growth YoY (Quarterly)
-36.5%
EPS growth YoY
-9%
EPS growth 3Y avg
N/A
EPS growth 5Y avg
3.7%

In the past 12 months, Prestige Consumer Healthcare has recorded an earnings per share growth rate of -36.5% (YoY, quarterly). In the last five years, the company had an average annual EPS growth of 3.7%. When assessed over a ten-year period, PBH's average EPS annual growth was 7.6%.

PBH Earnings Waterfall

Breakdown of revenue, profit and net income for Prestige Consumer Healthcare

PBH Earnings vs Peers

What are the earnings of PBH compared to its peers
Stock name Price to Earnings EPS grwoth 1Y EPS grwoth 3Y EPS grwoth 5Y
PBH Prestige Consumer Healthcare Inc 12.83 -9% N/A 3.7%
CLX Clorox Company 17.41 -26.5% 58.5% -3.2%
NVS Novartis AG 21.43 21.8% 31.2% 15.2%
PG Procter & Gamble Company 21.84 1.2% 3.6% 3.5%
CVS CVS Health Corp 22.36 -61.9% -24.8% -23.9%
JNJ Johnson & Johnson 30.83 90.6% 17.7% 14.8%
ABT Abbott Laboratories 33.38 -51.4% -1.8% 8.2%
PFE Pfizer Inc 37.08 -3.5% -37.4% -3.7%

All data is based on quarterly TTM periods, unless otherwise specified.